Advertisement

ADVERTISEMENT

Amanda Balbi

Conference Coverage
Migraine Does Not Worsen CVD Outcomes in Older Women
07/11/2019
A study presented at the American Headache Society’s 61st Annual Scientific Sessions investigated the correlation between migraine and cardiovascular disease outcomes among older women participating in the Women’s Health Initiative...
A study presented at the American Headache Society’s 61st Annual Scientific Sessions investigated the correlation between migraine and cardiovascular disease outcomes among older women participating in the Women’s Health Initiative...
A study presented at the...
07/11/2019
Neurology
Conference Coverage
Noninvasive Therapy for Chronic Migraine Shows Promise
07/11/2019
Study results presented at the American Headache Society’s 61st Annual Scientific Sessions highlight a non-invasive alternative to opioids for the treatment of chronic migraine.
Study results presented at the American Headache Society’s 61st Annual Scientific Sessions highlight a non-invasive alternative to opioids for the treatment of chronic migraine.
Study results presented at the...
07/11/2019
Neurology
Conference Coverage
Concussion: The 16-Year Headache
07/11/2019
In the keynote address at the American Headache Society’s 61st Annual Scientific Meeting, Chris Nowinski, PhD, co-founder of the Concussion Legacy Foundation, spoke about his struggle with post-concussive headaches, the lack of research in...
In the keynote address at the American Headache Society’s 61st Annual Scientific Meeting, Chris Nowinski, PhD, co-founder of the Concussion Legacy Foundation, spoke about his struggle with post-concussive headaches, the lack of research in...
In the keynote address at the...
07/11/2019
Neurology
News
FDA Approves First Treatment for Episodic Cluster Headaches
06/05/2019
After a clinical trial showed the treatment was more effective than placebo, the FDA approved the first treatment for episodic cluster headache in adults that reduces the frequency of attacks.
After a clinical trial showed the treatment was more effective than placebo, the FDA approved the first treatment for episodic cluster headache in adults that reduces the frequency of attacks.
After a clinical trial showed...
06/05/2019
Neurology
News
Does Bacterial Pneumonia Have Long-Term Effects in Children?
05/19/2019
“In previously healthy infants, following an episode of [acute respiratory failure] requiring [mechanical ventilation], development of [chronic pulmonary dysfunction] is common,” the researchers concluded.
“In previously healthy infants, following an episode of [acute respiratory failure] requiring [mechanical ventilation], development of [chronic pulmonary dysfunction] is common,” the researchers concluded.
“In previously healthy infants,...
05/19/2019
Pharmacy Learning Network
News
Infection During a Stroke Hospitalization Increases the Risk for Readmission
05/07/2019
According to new research, patients admitted to a hospital for a stroke who experience a common infection are over 20% more likely to be readmitted.
According to new research, patients admitted to a hospital for a stroke who experience a common infection are over 20% more likely to be readmitted.
According to new research,...
05/07/2019
Pharmacy Learning Network
News
Infection During a Stroke Hospitalization Increases the Risk for Readmission
05/06/2019
In a new review of more than 300,000 patients in the United States, researchers investigated whether common infections during a hospitalization for stroke affect readmission rate.
In a new review of more than 300,000 patients in the United States, researchers investigated whether common infections during a hospitalization for stroke affect readmission rate.
In a new review of more than...
05/06/2019
Neurology
News
FDA Approves Another New MS Treatment
04/01/2019
Following a clinical trial testing its safety and efficacy, the FDA has approved a new oral treatment for patients with relapsing forms of multiple sclerosis.
Following a clinical trial testing its safety and efficacy, the FDA has approved a new oral treatment for patients with relapsing forms of multiple sclerosis.
Following a clinical trial...
04/01/2019
Neurology
News
FDA Approves New MS Treatment
03/27/2019
The new oral treatment for multiple sclerosis is indicated for patients with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
The new oral treatment for multiple sclerosis is indicated for patients with clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease.
The new oral treatment for...
03/27/2019
Neurology
News
Antibiotic Prescriptions Reduced by Daily Probiotic Use
09/20/2018
Probiotic use reduces the need for antibiotic therapy in younger patients, according to a new study.
Probiotic use reduces the need for antibiotic therapy in younger patients, according to a new study.
Probiotic use reduces the need...
09/20/2018
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20
September 20 ⁠–⁠ September 22
September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use